Apex Biotechnology Corp (1733) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Apex Biotechnology Corp (1733) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$5.19 Million ≈ $163.42K USD) by net assets (NT$1.81 Billion ≈ $57.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Apex Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Apex Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Apex Biotechnology Corp (1733) total liabilities for a breakdown of total debt and financial obligations.

Apex Biotechnology Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apex Biotechnology Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
0.025x
QES Group Bhd
KLSE:0196
0.036x
Taiwan Takisawa Technology Co Ltd
TWO:6609
0.047x
Kluang Rubber Company Malaya
KLSE:2453
0.003x
KAISA GROUP HLDGS
F:KG5
N/A
Shine Justice Ltd
AU:SHJ
-0.049x
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
0.011x
Bathurst Resources Ltd
F:B0R
0.017x

Annual Cash Flow Conversion Efficiency for Apex Biotechnology Corp (2002–2024)

The table below shows the annual cash flow conversion efficiency of Apex Biotechnology Corp from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Apex Biotechnology Corp market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$1.82 Billion
≈ $57.47 Million
NT$328.67 Million
≈ $10.35 Million
0.180x +40.52%
2023-12-31 NT$1.80 Billion
≈ $56.61 Million
NT$230.39 Million
≈ $7.26 Million
0.128x +775.71%
2022-12-31 NT$1.82 Billion
≈ $57.27 Million
NT$26.62 Million
≈ $838.55K
0.015x -85.73%
2021-12-31 NT$1.75 Billion
≈ $55.25 Million
NT$179.87 Million
≈ $5.67 Million
0.103x -39.83%
2020-12-31 NT$1.65 Billion
≈ $51.86 Million
NT$280.60 Million
≈ $8.84 Million
0.170x -38.20%
2019-12-31 NT$1.68 Billion
≈ $52.83 Million
NT$462.52 Million
≈ $14.57 Million
0.276x +571.12%
2018-12-31 NT$1.64 Billion
≈ $51.79 Million
NT$67.57 Million
≈ $2.13 Million
0.041x -3.39%
2017-12-31 NT$1.66 Billion
≈ $52.45 Million
NT$70.83 Million
≈ $2.23 Million
0.043x -75.27%
2016-12-31 NT$1.73 Billion
≈ $54.58 Million
NT$298.06 Million
≈ $9.39 Million
0.172x -29.67%
2015-12-31 NT$1.93 Billion
≈ $60.80 Million
NT$472.15 Million
≈ $14.88 Million
0.245x +70.64%
2014-12-31 NT$1.87 Billion
≈ $58.80 Million
NT$267.60 Million
≈ $8.43 Million
0.143x -43.20%
2013-12-31 NT$1.92 Billion
≈ $60.51 Million
NT$484.77 Million
≈ $15.27 Million
0.252x -0.31%
2012-12-31 NT$2.01 Billion
≈ $63.41 Million
NT$509.67 Million
≈ $16.06 Million
0.253x +62.08%
2011-12-31 NT$1.75 Billion
≈ $55.14 Million
NT$273.45 Million
≈ $8.62 Million
0.156x -45.31%
2010-12-31 NT$1.63 Billion
≈ $51.35 Million
NT$465.59 Million
≈ $14.67 Million
0.286x +7.41%
2009-12-31 NT$1.47 Billion
≈ $46.35 Million
NT$391.29 Million
≈ $12.33 Million
0.266x +12.09%
2008-12-31 NT$1.26 Billion
≈ $39.83 Million
NT$299.96 Million
≈ $9.45 Million
0.237x -12.21%
2007-12-31 NT$1.35 Billion
≈ $42.50 Million
NT$364.62 Million
≈ $11.49 Million
0.270x -18.07%
2006-12-31 NT$1.10 Billion
≈ $34.74 Million
NT$363.71 Million
≈ $11.46 Million
0.330x +39.47%
2005-12-31 NT$896.93 Million
≈ $28.26 Million
NT$212.14 Million
≈ $6.68 Million
0.237x -6.29%
2004-12-31 NT$865.91 Million
≈ $27.28 Million
NT$218.54 Million
≈ $6.89 Million
0.252x -29.66%
2003-12-31 NT$842.42 Million
≈ $26.54 Million
NT$302.25 Million
≈ $9.52 Million
0.359x +221.73%
2002-12-31 NT$712.76 Million
≈ $22.46 Million
NT$79.49 Million
≈ $2.50 Million
0.112x --

About Apex Biotechnology Corp

TW:1733 Taiwan Biotechnology
Market Cap
$89.90 Million
NT$2.85 Billion TWD
Market Cap Rank
#19601 Global
#1132 in Taiwan
Share Price
NT$28.55
Change (1 day)
-0.52%
52-Week Range
NT$27.05 - NT$37.50
All Time High
NT$42.96
About

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health s… Read more